The medical device industry is under increasing pressure to adhere to FDA rules for process compliancy. Without compliance, these companies are unable to bring products to market and are subject to financial, civil and potentially criminal sanctions.
Along with increasing competition in the market for medical devices and the decreases in available staff, it’s clear why these companies look to effective methods for ensuring compliance with government policy and procedure while decreasing time-to-market and increasing competitiveness.
FDA 21 CFR Part 820 is a set of regulatory rules laid out by the U.S. Food and Drug Administration (FDA) for the purpose of ensuring the adequacy of quality systems involved in the manufacture of pharmaceutical products and medical devices. Unlike Part 11 Compliance, Part 820’s GMP regulations are mandatory for all medical device companies.